Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gates MRI is a nonprofit biotech organization focused on developing and advancing clinical-stage interventions—primarily vaccines and novel therapeutics—for global health diseases where commercial incentives are lacking, notably tuberculosis and malaria, with a growing focus on maternal and child health. The institute leads clinical trials from pre-clinical through Phase 3, collaborating extensively with industry and academia. Currently, it has programs in clinical trials for tuberculosis and malaria, including a licensed TB vaccine in Phase 3 development and a monoclonal antibody for malaria in clinical development[1][2][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gates Medical Research Institute.